Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia
Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia
Centralized Pan-Algerian Survey on the undertreatment of hypercholesterolemia. The purpose of
 this study is to establish the proportion of patients on lipid-lowering pharmacological
 treatment reaching the LDL-C goals according to the Third Joint European Task Force
 guidelines in the survey population.
Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia.
Inclusion Criteria:

 -  Subject must provide informed consent and comply with the survey procedures.

 -  Subject is on lipid lowering drug treatment for at least 3 months, with no dose change
 for a minimum of 6 weeks.

 Exclusion Criteria:

 - Subjects who are unwilling or unable to provide informed consent.